BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 12833894)

  • 41. [Ovarian cancers and CA 125 in 2006].
    Lambaudie E; Collinet P; Vinatier D
    Gynecol Obstet Fertil; 2006 Mar; 34(3):254-7. PubMed ID: 16529967
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Follow-up after the treatment of ovarian cancer - really without Ca 125?].
    Freitag P
    Ceska Gynekol; 2012 Dec; 77(6):540-2. PubMed ID: 23521196
    [TBL] [Abstract][Full Text] [Related]  

  • 43. ACR Appropriateness Criteria on staging and follow-up of ovarian cancer.
    Javitt MC
    J Am Coll Radiol; 2007 Sep; 4(9):586-9. PubMed ID: 17845961
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ovarian cancer: an overview of treatment options.
    Martin VR
    Clin J Oncol Nurs; 2007 Apr; 11(2):201-7. PubMed ID: 17573269
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Epithelial ovarian cancer: future prospects for treatment.
    Shelling AN; Cooke IE; Le Meuth VG; Ganesan TS
    N Z Med J; 1996 Apr; 109(1020):131-2. PubMed ID: 8649666
    [No Abstract]   [Full Text] [Related]  

  • 46. The medical-surgical nurse's guide to ovarian cancer: part I.
    Bohnenkamp S; LeBaron V; Yoder LH
    Medsurg Nurs; 2007 Aug; 16(4):259-66; quiz 267. PubMed ID: 17907699
    [No Abstract]   [Full Text] [Related]  

  • 47. [Ovarian carcinoma: certain characteristics of evolution, advancement and diagnosis].
    Prokopenko PG; Terent'ev AA
    Vopr Onkol; 2009; 55(2):143-50. PubMed ID: 19514366
    [No Abstract]   [Full Text] [Related]  

  • 48. [Is it possible to have organized screening for ovarian cancer?].
    Navone R; Montanari G
    Pathologica; 2003 Apr; 95(2):67-70. PubMed ID: 12768874
    [No Abstract]   [Full Text] [Related]  

  • 49. Spontaneous regression in recurrent epithelial ovarian cancer.
    Fujiwaki R; Sawada K
    Arch Gynecol Obstet; 2007 May; 275(5):389-91. PubMed ID: 17177031
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Treatment opportunity and strategy for recurrent ovarian cancer].
    Pan LY; Jin Y; Huang HF; Shen K; Wu M; Lang JH
    Ai Zheng; 2003 Nov; 22(11):1188-92. PubMed ID: 14613650
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Diagnosis and treatment of ovarian cancer.
    Best C; Pratt H
    Nurs Times; 1999 Jun 16-22; 95(24):50-2. PubMed ID: 10455737
    [No Abstract]   [Full Text] [Related]  

  • 52. Extraovarian primary peritoneal carcinoma in a child.
    Shibata R; Matsufuji H; Morimoto T; Hosoya R; Araki A; Hata J
    Pediatr Blood Cancer; 2004 Mar; 42(3):292-3. PubMed ID: 14752872
    [No Abstract]   [Full Text] [Related]  

  • 53. [Ovarian carcinoma].
    Engeler V
    Fortschr Geburtshilfe Gynakol; 1974; 53():1-116. PubMed ID: 4442831
    [No Abstract]   [Full Text] [Related]  

  • 54. Listen for the "whispering disease". Learn the subtle signs and symptoms of ovarian cancer.
    Martin VR
    Nurs Manage; 2000 Apr; 31(4):30-1. PubMed ID: 15127636
    [No Abstract]   [Full Text] [Related]  

  • 55. Autoimmune hemolytic anemia associated with ovarian cancer.
    Morris PG; Swords R; Sukor S; Fortune A; O'Donnell DM; Conneally E
    J Clin Oncol; 2008 Oct; 26(30):4993-5. PubMed ID: 18809611
    [No Abstract]   [Full Text] [Related]  

  • 56. Screening and detection of ovarian cancer.
    Breedlove G; Busenhart C
    J Midwifery Womens Health; 2005; 50(1):51-4. PubMed ID: 15637515
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Primary and metastatic ovarian cancer in patients with prior breast carcinoma. Pre-operative markers and treatment results.
    Tserkezoglou A; Kontou S; Hadjieleftheriou G; Apostolikas N; Vassilomanolakis M; Sikiotis K; Salamalekis E; Tseke P; Magiakos G
    Anticancer Res; 2006; 26(3B):2339-44. PubMed ID: 16821613
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Soluble epidermal growth factor receptor (sEGFR) [corrected] and cancer antigen 125 (CA125) as screening and diagnostic tests for epithelial ovarian cancer.
    Baron AT; Boardman CH; Lafky JM; Rademaker A; Liu D; Fishman DA; Podratz KC; Maihle NJ
    Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):306-18. PubMed ID: 15734951
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Carcinoma erysipeloides from ovarian clear-cell carcinoma.
    Lee HC; Chu CY; Hsiao CH
    J Clin Oncol; 2007 Dec; 25(36):5828-30. PubMed ID: 18089882
    [No Abstract]   [Full Text] [Related]  

  • 60. Epithelial ovarian carcinoma: ESMO clinical recommendations for diagnosis, treatment and follow-up.
    Aebi S; Castiglione M;
    Ann Oncol; 2008 May; 19 Suppl 2():ii14-6. PubMed ID: 18456751
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.